[Viewpoint of the German Dermatologic Society (DDG) concerning the decision of the American Food and Drug Administration (FDA) on the use of pimecrolimus cream and tacrolimus ointment in the treatment of atopic dermatitis (neurodermatitis)].

Authors	Thomas A Luger, Harald Gollnick
Journal	Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (J Dtsch Dermatol Ges) Vol. 3 Issue 6 Pg. 415-6 (Jun 2005) ISSN: 1610-0379 [Print] Germany
Vernacular Title	Stellungnahme der Deutschen Dermatologischen Gesellschaft (DDG) zur Entscheidung der amerikanischen Arzneimittelbehörde (FDA) über die Verwendung von Pimecrolimus-Creme und Tacrolimus-Salbe zur Behandlung der Atopischen Dermatitis (Neurodermitis).
PMID	15892843 (Publication Type: Editorial)
Chemical References	Dermatologic Agents Immunosuppressive Agents Ointments pimecrolimus Tacrolimus
Topics	Dermatitis, Atopic (drug therapy) Dermatologic Agents (administration & dosage) Dermatology Germany Humans Immunosuppressive Agents (administration & dosage) Ointments Societies, Medical Tacrolimus (administration & dosage, analogs & derivatives) United States United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!